MedTrace Logo

Open Dialogue About Complementary Alternative Medicine (CAM) Integrated in Conventional Oncology Care

NCT03857776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2021-04-29

No results posted yet for this study

Summary

The purpose of this phase two parallel-group randomized controlled trial is to assess the efficacy of open dialogue about CAM integrated in conventional oncology care. The investigators hypothesize that patients in the intervention group participating in a scheduled open dialogue with a nurse specialist about CAM will experience better physical and mental health compared to patients in the control group receiving standard care alone.

Conditions

Interventions

OTHER

Open dialogue about complementary alternative medicine

1-hour dialogue about CAM with a nurse specialist as an Integrated part of conventional oncology care

OTHER

Standard care

Standard care including referral to a homepage about CAM

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Lars Henrik Jensen · Department of Oncology, Vejle Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-05
Primary Completion
2020-05-24
Completion
2020-05-24

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03857776 on ClinicalTrials.gov